BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30529227)

  • 21. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
    Steinacker P; Blennow K; Halbgebauer S; Shi S; Ruf V; Oeckl P; Giese A; Kuhle J; Slivarichova D; Zetterberg H; Otto M
    Sci Rep; 2016 Dec; 6():38737. PubMed ID: 27929120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CSF analysis of patients with prion disease by biomarkers and real-time qucking-induced conversion (RT-QUIC) method].
    Satoh K
    Rinsho Shinkeigaku; 2013; 23(11):1252-4. PubMed ID: 24291947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
    Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
    Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt-Jakob disease in clinical practice.
    Fayolle M; Lehmann S; Delaby C
    J Neural Transm (Vienna); 2022 Feb; 129(2):133-139. PubMed ID: 35041062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF biomarkers for prion diseases.
    Satoh K
    Neurochem Int; 2022 May; 155():105306. PubMed ID: 35176437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
    Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
    Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.
    Connor A; Wang H; Appleby BS; Rhoads DD
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31366689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.
    Mok TH; Nihat A; Luk C; Sequeira D; Batchelor M; Mead S; Collinge J; Jackson GS
    Sci Rep; 2021 Mar; 11(1):5231. PubMed ID: 33664355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
    Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
    J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion.
    Schmitz M; Candelise N; Llorens F; Zerr I
    Methods Mol Biol; 2018; 1779():257-263. PubMed ID: 29886538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
    Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of CJD from nasal brushings but not spinal fluid or RT-QuIC product.
    Raymond GJ; Race B; Orrú CD; Raymond LD; Bongianni M; Fiorini M; Groveman BR; Ferrari S; Sacchetto L; Hughson AG; Monaco S; Pocchiari M; Zanusso G; Caughey B
    Ann Clin Transl Neurol; 2020 Jun; 7(6):932-944. PubMed ID: 32538552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of prion diseases by RT-QuIC results in improved surveillance.
    Rhoads DD; Wrona A; Foutz A; Blevins J; Glisic K; Person M; Maddox RA; Belay ED; Schonberger LB; Tatsuoka C; Cohen ML; Appleby BS
    Neurology; 2020 Aug; 95(8):e1017-e1026. PubMed ID: 32571851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease.
    Cramm M; Schmitz M; Karch A; Mitrova E; Kuhn F; Schroeder B; Raeber A; Varges D; Kim YS; Satoh K; Collins S; Zerr I
    Mol Neurobiol; 2016 Apr; 53(3):1896-1904. PubMed ID: 25823511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease.
    Halbgebauer S; Abu-Rumeileh S; Oeckl P; Steinacker P; Roselli F; Wiesner D; Mammana A; Beekes M; Kortazar-Zubizarreta I; Perez de Nanclares G; Capellari S; Giese A; Castilla J; Ludolph AC; Žáková D; Parchi P; Otto M
    Neurology; 2022 Apr; 98(14):e1434-e1445. PubMed ID: 35110380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
    Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].
    Zetterberg H; Hammarin AL; Nilsson P; Andersson E; Lind B; Blennow K
    Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):956-8, 960-1. PubMed ID: 15887642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
    Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S
    Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt-Jakob disease: a (network) meta-analysis.
    Rübsamen N; Pape S; Konigorski S; Zapf A; Rücker G; Karch A
    Eur J Neurol; 2022 May; 29(5):1366-1376. PubMed ID: 35075751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.